Clotrimazole and Mestinon drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Clotrimazole and Mestinon. Common interactions include urosepsis among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people who take Clotrimazole and Mestinon have. It is created by eHealthMe based on reports of 11 people who take Clotrimazole and Mestinon from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 16, 2022

11 people who take Clotrimazole and Mestinon together, and have interactions are studied.

What is Clotrimazole?

Clotrimazole has active ingredients of clotrimazole. It is often used in thrush. eHealthMe is studying from 11,245 Clotrimazole users for its effectiveness, alternative drugs and more.

What is Mestinon?

Mestinon has active ingredients of pyridostigmine bromide. It is often used in myasthenia gravis. eHealthMe is studying from 4,688 Mestinon users for its effectiveness, alternative drugs and more.

Number of Clotrimazole and Mestinon reports submitted per year:

Common Clotrimazole and Mestinon drug interactions by gender *:

female:

Urosepsis
Vision blurred
Vitreous floaters
Diarrhoea
Nausea
Dyskinesia
Endocarditis
Enterococcal sepsis
Hypotonia
Metapneumovirus infection

male:

Dyspnoea
Skin reaction

Common Clotrimazole and Mestinon drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Vomiting
Dyskinesia
Dyspnoea
Hypotonia
Mydriasis
Pain in extremity
Pulmonary embolism
Cellulitis
Dehydration
Diarrhoea

50-59:

Actinic keratosis
Adenoma benign
Adverse drug reaction
B-lymphocyte count decreased
Blood immunoglobulin a decreased
Cd4 lymphocytes decreased
Chills
Dacryocystitis
Diarrhoea
Drug ineffective

60+:

Dyspnoea
Cystitis
Endocarditis
Enterococcal sepsis
Metapneumovirus infection
Urinary tract infection
Skin reaction
Back pain
Actinic keratosis
Adenoma benign

Common conditions people have *:

Wheezing (a high-pitched whistling sound made while you breath): 3 people, 27.27%
Pulmonary Congestion (congestion in the lungs): 3 people, 27.27%
Insomnia (sleeplessness): 3 people, 27.27%
Dry Eyes (lack of adequate tears): 3 people, 27.27%
Diarrhea: 3 people, 27.27%
Cough: 3 people, 27.27%
Constipation: 3 people, 27.27%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 2 people, 18.18%
Pericarditis (inflammation of the pericardium): 2 people, 18.18%
Osteoporosis (bones weak and more likely to break): 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Clotrimazole and Mestinon?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Clotrimazole (11,245 reports)
Mestinon (4,688 reports)